Overview

A Study to Investigate PK, Safety, Tolerability of Cefepime-enmetazobactam in Pediatric Participants With cUTI

Status:
Not yet recruiting

Trial end date:
2026-03-30

Target enrollment:

Participant gender:

Summary

This phase 2 study is part of regulatory commitments in the United States (PSP) and Europe (PIP) to evaluate cefepime-enmetazobactam in paediatric participants with cUTI to support extension of the indication for cefepime-enmetazobactam to children with cUTI.

Phase:

Phase 2

Details

Lead Sponsor:

Allecra

Collaborator:

Linical Co., Ltd.

Treatments:

Cefepime
Enmetazobactam